Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Allergic Rhinitis Drugs Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Antihistamines
  • 1.3.3 Intranasal Corticosteroids
  • 1.3.4 Immunotherapies
• 1.4 Market Segment by Application
  • 1.4.1 Global Allergic Rhinitis Drugs Market Share by Application (2019-2025)
  • 1.4.2 Hospital Pharmacy
  • 1.4.3 Retail Pharmacy
  • 1.4.4 Online Pharmacy
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Allergic Rhinitis Drugs Market Size
  • 2.1.1 Global Allergic Rhinitis Drugs Revenue 2014-2025
  • 2.1.2 Global Allergic Rhinitis Drugs Sales 2014-2025
• 2.2 Allergic Rhinitis Drugs Growth Rate by Regions
  • 2.2.1 Global Allergic Rhinitis Drugs Sales by Regions 2014-2019
  • 2.2.2 Global Allergic Rhinitis Drugs Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Allergic Rhinitis Drugs Sales by Manufacturers
  • 3.1.1 Allergic Rhinitis Drugs Sales by Manufacturers 2014-2019
  • 3.1.2 Allergic Rhinitis Drugs Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Allergic Rhinitis Drugs Revenue by Manufacturers (2014-2019)
  • 3.2.2 Allergic Rhinitis Drugs Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Allergic Rhinitis Drugs Market Concentration Ratio (CR5 and HHI)
• 3.3 Allergic Rhinitis Drugs Price by Manufacturers
• 3.4 Key Manufacturers Allergic Rhinitis Drugs Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Allergic Rhinitis Drugs Market
• 3.6 Key Manufacturers Allergic Rhinitis Drugs Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Antihistamines Sales and Revenue (2014-2019)
  • 4.1.2 Intranasal Corticosteroids Sales and Revenue (2014-2019)
  • 4.1.3 Immunotherapies Sales and Revenue (2014-2019)
• 4.2 Global Allergic Rhinitis Drugs Sales Market Share by Type
• 4.3 Global Allergic Rhinitis Drugs Revenue Market Share by Type
• 4.4 Allergic Rhinitis Drugs Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Allergic Rhinitis Drugs Sales by Application

6 United States

• 6.1 United States Allergic Rhinitis Drugs Breakdown Data by Company
• 6.2 United States Allergic Rhinitis Drugs Breakdown Data by Type
• 6.3 United States Allergic Rhinitis Drugs Breakdown Data by Application

7 European Union

• 7.1 European Union Allergic Rhinitis Drugs Breakdown Data by Company
• 7.2 European Union Allergic Rhinitis Drugs Breakdown Data by Type
• 7.3 European Union Allergic Rhinitis Drugs Breakdown Data by Application

8 China

• 8.1 China Allergic Rhinitis Drugs Breakdown Data by Company
• 8.2 China Allergic Rhinitis Drugs Breakdown Data by Type
• 8.3 China Allergic Rhinitis Drugs Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Allergic Rhinitis Drugs Breakdown Data by Company
• 9.2 Rest of World Allergic Rhinitis Drugs Breakdown Data by Type
• 9.3 Rest of World Allergic Rhinitis Drugs Breakdown Data by Application
• 9.4 Rest of World Allergic Rhinitis Drugs Breakdown Data by Countries
  • 9.4.1 Rest of World Allergic Rhinitis Drugs Sales by Countries
  • 9.4.2 Rest of World Allergic Rhinitis Drugs Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 GlaxoSmithKline
  • 10.1.1 GlaxoSmithKline Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Allergic Rhinitis Drugs
  • 10.1.4 Allergic Rhinitis Drugs Product Introduction
  • 10.1.5 GlaxoSmithKline Recent Development
• 10.2 Sanofi
  • 10.2.1 Sanofi Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Allergic Rhinitis Drugs
  • 10.2.4 Allergic Rhinitis Drugs Product Introduction
  • 10.2.5 Sanofi Recent Development
• 10.3 ALK-Abelló
  • 10.3.1 ALK-Abelló Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Allergic Rhinitis Drugs
  • 10.3.4 Allergic Rhinitis Drugs Product Introduction
  • 10.3.5 ALK-Abelló Recent Development
• 10.4 Meda Pharmaceuticals
  • 10.4.1 Meda Pharmaceuticals Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Allergic Rhinitis Drugs
  • 10.4.4 Allergic Rhinitis Drugs Product Introduction
  • 10.4.5 Meda Pharmaceuticals Recent Development
• 10.5 Adamis Pharmaceuticals
  • 10.5.1 Adamis Pharmaceuticals Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Allergic Rhinitis Drugs
  • 10.5.4 Allergic Rhinitis Drugs Product Introduction
  • 10.5.5 Adamis Pharmaceuticals Recent Development
• 10.6 Allergy Therapeutics
  • 10.6.1 Allergy Therapeutics Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Allergic Rhinitis Drugs
  • 10.6.4 Allergic Rhinitis Drugs Product Introduction
  • 10.6.5 Allergy Therapeutics Recent Development
• 10.7 Almirall
  • 10.7.1 Almirall Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Allergic Rhinitis Drugs
  • 10.7.4 Allergic Rhinitis Drugs Product Introduction
  • 10.7.5 Almirall Recent Development
• 10.8 Ampio
  • 10.8.1 Ampio Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Allergic Rhinitis Drugs
  • 10.8.4 Allergic Rhinitis Drugs Product Introduction
  • 10.8.5 Ampio Recent Development
• 10.9 AstraZeneca
  • 10.9.1 AstraZeneca Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Allergic Rhinitis Drugs
  • 10.9.4 Allergic Rhinitis Drugs Product Introduction
  • 10.9.5 AstraZeneca Recent Development
• 10.10 Amneal Pharmaceuticals
  • 10.10.1 Amneal Pharmaceuticals Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Allergic Rhinitis Drugs
  • 10.10.4 Allergic Rhinitis Drugs Product Introduction
  • 10.10.5 Amneal Pharmaceuticals Recent Development
• 10.11 Anergis
• 10.12 Apotex
• 10.13 Array BioPharma
• 10.14 Aspen Pharmacare
• 10.15 Circassia Pharmaceuticals
• 10.16 Dr Reddy's Laboratories
• 10.17 Eddingpharm
• 10.18 EMS
• 10.19 HAL Allergy
• 10.20 Inmunotek
• 10.21 Genentech
• 10.22 Greer Laboratories
• 10.23 Glenmark Pharmaceuticals
• 10.24 Hanmi Pharmaceuticals
• 10.25 Hisamitsu Pharmaceutical
• 10.26 Intas Pharmaceuticals
• 10.27 Novartis

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Allergic Rhinitis Drugs Sales Channels
  • 11.2.2 Allergic Rhinitis Drugs Distributors
• 11.3 Allergic Rhinitis Drugs Customers

12 Market Forecast

• 12.1 Global Allergic Rhinitis Drugs Sales and Revenue Forecast 2019-2025
• 12.2 Global Allergic Rhinitis Drugs Sales Forecast by Type
• 12.3 Global Allergic Rhinitis Drugs Sales Forecast by Application
• 12.4 Allergic Rhinitis Drugs Forecast by Regions
  • 12.4.1 Global Allergic Rhinitis Drugs Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Allergic Rhinitis Drugs Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In individuals with allergic rhinitis, the immune system overreacts and causes an allergic reaction when allergens such as pollen, mold, and dander come in contact with the immune system. 
The Americas accounted for the major shares of the allergy rhinitis drugs market during 2016. In the Americas, the US accounted for a major share and this attribute to factors such as the growing prevalence of infectious diseases, especially allergy rhinitis in the country. 
In 2019, the market size of Allergic Rhinitis Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Allergic Rhinitis Drugs.

This report studies the global market size of Allergic Rhinitis Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Allergic Rhinitis Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GlaxoSmithKline
Sanofi
ALK-Abelló
Meda Pharmaceuticals
Adamis Pharmaceuticals
Allergy Therapeutics
Almirall
Ampio
AstraZeneca
Amneal Pharmaceuticals
Anergis
Apotex
Array BioPharma
Aspen Pharmacare
Circassia Pharmaceuticals
Dr Reddy's Laboratories
Eddingpharm
EMS
HAL Allergy
Inmunotek
Genentech
Greer Laboratories
Glenmark Pharmaceuticals
Hanmi Pharmaceuticals
Hisamitsu Pharmaceutical
Intas Pharmaceuticals
Novartis

Market Segment by Product Type
Antihistamines
Intranasal Corticosteroids
Immunotherapies

Market Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Allergic Rhinitis Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Allergic Rhinitis Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Allergic Rhinitis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025